139 related articles for article (PubMed ID: 15982575)
1. Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation.
Mansard S; Papon J; Moreau MF; Miot-Noirault E; Labarre P; Bayle M; Veyre A; Madelmont JC; Moins N
Nucl Med Biol; 2005 Jul; 32(5):451-8. PubMed ID: 15982575
[TBL] [Abstract][Full Text] [Related]
2. Distribution of I-BZA (N-2-diethylaminoethyl-4-iodobenzamide) in grafted melanoma and normal skin: a study by secondary ion mass spectroscopy.
Chehade F; De Labriolle-Vaylet C; Michelot J; Moins N; Moreau MF; Hindié E; Papon J; Escaig F; Galle P; Veyre A
Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):529-34. PubMed ID: 11441960
[TBL] [Abstract][Full Text] [Related]
3. Localization of N-(2-diethylaminoethyl)4-iodobenzamide in the pigmented mouse eye: a microanalytical study.
Chehade F; Michelot J; Hindié E; Papon J; Delabriolle-Vaylet C; Zhang L; Escaig F; Moreau MF; Veyre A
Cell Mol Biol (Noisy-le-grand); 1996 May; 42(3):343-50. PubMed ID: 8793189
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro binding and biodistribution in B16 melanoma-bearing mice of new iodine-125 spermidine benzamide derivatives.
Moreau MF; Papon J; Labarre P; Moins N; Borel M; Bayle M; Bouchon B; Madelmont JC
Nucl Med Biol; 2005 May; 32(4):377-84. PubMed ID: 15878507
[TBL] [Abstract][Full Text] [Related]
5. Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexes [(Cp-R)99mTc(CO)3] mimicking benzamides for malignant melanoma targeting.
N'Dongo HW; Raposinho PD; Fernandes C; Santos I; Can D; Schmutz P; Spingler B; Alberto R
Nucl Med Biol; 2010 Apr; 37(3):255-64. PubMed ID: 20346865
[TBL] [Abstract][Full Text] [Related]
6. Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.
Labarre P; Papon J; Rose AH; Guerquin-Kern JL; Morandeau L; Wu TD; Moreau MF; Bayle M; Chezal JM; Croisy A; Madelmont JC; Turner H; Moins N
Nucl Med Biol; 2008 Oct; 35(7):783-91. PubMed ID: 18848663
[TBL] [Abstract][Full Text] [Related]
7. Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent.
Labarre P; Papon J; Moreau MF; Moins N; Bayle M; Veyre A; Madelmont JC
Melanoma Res; 2002 Apr; 12(2):115-21. PubMed ID: 11930107
[TBL] [Abstract][Full Text] [Related]
8. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
[TBL] [Abstract][Full Text] [Related]
9. Role of acidic cell organelles in the higher nonmelanoma retention of melanoma markers based on N-(2-dialkylaminoethyl)benzamides and the cytotoxicity of alkylating benzamides.
Wolf M; Bauder-Wüst U; Eskerski H; Bauer C; Eisenhut M
Melanoma Res; 2007 Apr; 17(2):61-73. PubMed ID: 17496781
[TBL] [Abstract][Full Text] [Related]
10. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
[TBL] [Abstract][Full Text] [Related]
11. Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.
Chéhadé F; de Labriolle-Vaylet C; Moins N; Moreau MF; Papon J; Labarre P; Galle P; Veyre A; Hindié E
J Nucl Med; 2005 Oct; 46(10):1701-6. PubMed ID: 16204721
[TBL] [Abstract][Full Text] [Related]
12. Tracers for imaging melanin with positron emission tomography.
Sadzot B; Sheldon J; Flesher J; Dannals RF; Schachat AP; Frost JJ
Synapse; 1999 Jan; 31(1):5-12. PubMed ID: 10025678
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of a novel Al(18)F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma.
Chang CC; Chang CH; Lo YH; Lin MH; Shen CC; Liu RS; Wang HE; Chen CL
Bioorg Med Chem Lett; 2016 Aug; 26(16):4133-9. PubMed ID: 27445169
[TBL] [Abstract][Full Text] [Related]
14. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
Moins N; D'Incan M; Bonafous J; Bacin F; Labarre P; Moreau MF; Mestas D; Noirault E; Chossat F; Berthommier E; Papon J; Bayle M; Souteyrand P; Madelmont JC; Veyre A
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1478-84. PubMed ID: 12397467
[TBL] [Abstract][Full Text] [Related]
15. Selective incorporation of L-3,4-dihydroxyphenylalanine by S-91 Cloudman melanoma in vitro.
Wick MM; Frei E
Cancer Res; 1977 Jul; 37(7 Pt 1):2123-5. PubMed ID: 861938
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
[TBL] [Abstract][Full Text] [Related]
18. [4-t-butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs.
Na YJ; Baek HS; Ahn SM; Shin HJ; Chang IS; Hwang JS
Biochem Pharmacol; 2007 Sep; 74(5):780-6. PubMed ID: 17658483
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
